Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Haab

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 2011
[Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy]J-N Cornu, C Doucet, P Sèbe, et al.
The Annals of Thoracic Surgery|July 1, 1994
Long-term effects of dynamic aortomyoplastyJ C Chachques, F Haab, C Cron, et al.
International Journal of Clinical Practice|December 16, 2014
Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studiesF Bunn, M Kirby, E Pinkney, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2009
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]B Perrouin-Verbe, A Ruffion, X Gamé, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|June 3, 2008
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients]M de Sèze, A Ruffion, F Haab, et al.
International Journal of Clinical Practice|September 20, 2006
Overactive bladder: The importance of new guidanceM Kirby, W Artibani, L Cardozo, et al.
International Journal of Clinical Practice|September 30, 2008
Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?A Wagg, L Cardozo, C Chapple, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 4, 2014
[Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome]X Deffieux, B Fatton, P Denys, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 13, 2014
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendationsJ-F Hermieu, P Ballanger, G Amarenco, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 10, 2015
[Idiopathic overactive bladder and BOTOX(®): Literature review]X Gamé, G Karsenty, A Ruffion, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 1, 2011
[Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy]J-N Cornu, C Doucet, P Sèbe, et al.
The Annals of Thoracic Surgery|July 1, 1994
Long-term effects of dynamic aortomyoplastyJ C Chachques, F Haab, C Cron, et al.
International Journal of Clinical Practice|December 16, 2014
Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studiesF Bunn, M Kirby, E Pinkney, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2009
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]B Perrouin-Verbe, A Ruffion, X Gamé, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|June 3, 2008
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients]M de Sèze, A Ruffion, F Haab, et al.
International Journal of Clinical Practice|September 20, 2006
Overactive bladder: The importance of new guidanceM Kirby, W Artibani, L Cardozo, et al.
International Journal of Clinical Practice|September 30, 2008
Overactive Bladder and Continence Guidelines: implementation, inaction or frustration?A Wagg, L Cardozo, C Chapple, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|August 4, 2014
[Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome]X Deffieux, B Fatton, P Denys, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 13, 2014
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendationsJ-F Hermieu, P Ballanger, G Amarenco, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 10, 2015
[Idiopathic overactive bladder and BOTOX(®): Literature review]X Gamé, G Karsenty, A Ruffion, et al.
Pageof 14